According to IQVIA™ sales data for the 12-month period ending December 2024, the Evoclin® Foam, 1% market3achieved annual sales of approximately $5.8 million*. About Glenmark Pharmaceuticals Ltd.

Glenmark Pharma’s licensing pact for its investigational cancer drug ISB 2001 is not just a deal --it’s a turning point in Indian pharma/biotech innovation. It ...

Glenmark Pharmaceuticals Ltd, a research-led, global pharmaceutical company has launched Tevimbra (tislelizumab) to offer immuno-oncology treatment for lung and esophageal cancer in India following ...